artificial intelligence

News

Change at the top of Recursion as co-founder leaves CEO role

After 12 years as CEO of 'techbio' player Recursion, Chris Gibson is switching to the role of chair and will be replaced by Najat Khan.

News

AI features in UK plan to reduce animal testing

The UK government has set out an ambitious plan to phase out animal testing in scientific studies within five years.

News

Lilly partners NVIDIA to build 'most powerful' supercomputer

Eli Lilly and NVIDIA have joined forces on an ambitious plan – building pharma's most powerful AI-powered supercomputer for drug discovery.

News

UK and US agencies team up for medtech, AI regulation

The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical technologies and AI.

News

Ignota's co-founder and chief executive, Sam Windsor

Ignota vacuums up Kronos Bio's drug programmes

Ignota Labs of the UK has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US firm ceased operations earlier this year.

News

Roche gets EU nod for kidney disease algorithm

Roche and Klinrisk have picked up a CE-mark for an AI tool that can be used to predict renal function decline in patients with chronic kidney disease.

Change at the top of Recursion as co-founder leaves CEO role

AI features in UK plan to reduce animal testing

Lilly partners NVIDIA to build 'most powerful' supercomputer

UK and US agencies team up for medtech, AI regulation

Ignota vacuums up Kronos Bio's drug programmes

Roche gets EU nod for kidney disease algorithm

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

artificial intelligence

Editor's Picks